Nurse Practitioner, Adult Health · New York, NY
NPI
1487305967
Since 2022
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
520 E. 70th Street, Starr 4
New York, NY, 10021
Phone (516) 946-3456
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,011
25 services
Medicare patients, 2024
18
Average age 78
Drug cost, 2024
$4.2M
3,471 prescriptions
Company payments, 2025
$428
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christine M Krisch was code 36415 (venipuncture blood collection), 13 times for 13 patients. In total Christine M Krisch billed 25 services in 6 codes, and Medicare paid $1,011.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 13 | 13 | $8.65 | $112 |
By year: 2023 $759 for 26 services; 2024 $1,011 for 25 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 13 | 13 | $8.65 | $112 |
Medicare prescription drug claims, 2024
In 2024, the drug Christine M Krisch prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 282 prescriptions and refills. In total Christine M Krisch wrote 3,471 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 282 | 548 | 90 | $359K |
| Farxiga Dapagliflozin Propanediol | 258 | 543 | 78 | $299K |
| Metoprolol Succinate Generic | 242 | 645 | 89 | $3,875 |
| Spironolactone Generic | 196 | 460 | 67 | $1,609 |
| Eplerenone Generic | 190 | 527 | 70 | $16K |
| Eliquis Apixaban | 175 | 328 | 57 | $191K |
| Carvedilol Generic | 166 | 457 | 63 | $1,678 |
| Atorvastatin Calcium Generic | 146 | 412 | 65 | $1,463 |
| Furosemide Generic | 102 | 255 | 47 | $563 |
| Bumetanide Generic | 95 | 189 | 38 | $3,597 |
| Jardiance Empagliflozin | 89 | 164 | 27 | $93K |
| Warfarin Sodium Generic | 87 | 195 | 31 | $1,034 |
| Losartan Potassium Generic | 86 | 244 | 41 | $818 |
| Torsemide Generic | 80 | 195 | 31 | $1,789 |
| Rosuvastatin Calcium Generic | 80 | 225 | 29 | $1,603 |
Brand drugs: 1,156 claims; generic drugs: 2,315 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christine M Krisch $428 ($428 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbott Laboratories with $193.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.